Posts classified under: H

Victoria Ho, M.D., Ph.D.

Faculty Member

Assistant Professor in Residence
Department of Neurology
David Geffen School of Medicine
University of California, Los Angeles

Personal Statement

My lab aims to advance epilepsy treatment by understanding the epileptogenic processes that lead to recurrent seizures and cognitive dysfunction. I began studying the hippocampus as a graduate student, examining the post-transcriptional mechanisms of synaptic plasticity in primary neuronal and glial co-cultures. I continue to investigate the mechanisms of plasticity in the adult hippocampus, now in the pathological context of epileptogenesis in mouse models of epilepsy. As an epileptologist, I am privileged to participate in the care of Veterans with medication refractory epilepsy. Despite the expanding repertoire of treatments for seizures, we still lack therapies to prevent or cure epileptogenesis. Additionally, many epilepsy patients are also burdened with comorbid cognitive impairment, for which there are no treatments. These unmet needs are the primary motivation that guides my lab’s preclinical experimentation.

To elucidate the mechanisms underlying epileptogenesis, we have used single cell sequencing to profile cell type specific transcriptomic changes in the pilocarpine model of temporal lobe epilepsy. Many of our sequencing findings are concordant with existing literature on changes that occur during epileptogenesis, and have also generated several novel hypotheses for further exploration. One of the revelations from the data is the transcriptomically distinct population of microglia that are abundant in epileptic hippocampi, which we call epilepsy-associated microglia (EAM). The EAM share several genes with disease-associated microglia in other neurological disorders with increased risk for epilepsy, including Alzheimer’s disease and traumatic brain injury.
Our follow-up studies with immunostaining and electron microscopy indicate that EAM have an “activated” phenotype. Experiments to dissect the pro- and anti-epileptogenic potential of these microglia will be pursued in the proposed studies.

Nina Harawa, Ph.D., M.P.H.

Faculty Member

Professor
Department of Medicine
David Geffen School of Medicine
University of California, Los Angeles


Personal Statement

My research in the areas of HIV, substance use disorder, and incarceration involves substantial proportion of individuals with mental illness, brain injuries, PTSD, and intellectual disabilities. I am interested in the potential for collaborations with BRI researchers that might support or inform improved health for these populations.

Gil Hoftman, M.D., Ph.D.

Biography

Dr. Hoftman’s laboratory works in the areas of genetic and clinical high risk for psychosis, schizophrenia, and neurodevelopment using imaging transcriptomics and molecular neuroscience, with the goal of connecting the molecular underpinnings of disruptions in neural circuitry in psychosis risk to in vivo human brain development. His research is or has been funded by the National Institute of Mental Health, Burroughs Wellcome Fund Career Award for Medical Scientists, Sorensen Foundation Award for Child & Adolescent Psychiatrists, Brain and Behavior Research Foundation NARSAD Karen Seykora Young Investigator Award, UCLA Friends of Semel Institute Award, and Della Martin Award. Dr. Hoftman is dedicated to delivering evidence based TMS treatment for depression and numerous additional conditions offered in clinic, as well as its applications for psychosis and in children and adolescents.

1 2 3 6